Chinese biopharmaceutical company Shanghai Junshi Biosciences Co. has filed for a US$414 million initial public offering in Hong Kong, according to a security filing released today.
Chinese Biopharmaceutical Firm Junshi Biosciences Targets $414M IPO In Hong Kong appeared first on China Money Network.